| Estimating the effectiveness of DPYD genotyping in Italian individuals suffering from cancer based on the cost of chemotherapy-induced toxicity V Fragoulakis, R Roncato, C Dalle Fratte, F Ecca, M Bartsakoulia, ... The American Journal of Human Genetics 104 (6), 1158-1168, 2019 | 45 | 2019 |
| The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice G Toffoli, F Innocenti, J Polesel, E De Mattia, F Sartor, C Dalle Fratte, ... Clinical Pharmacology & Therapeutics 105 (4), 994-1002, 2019 | 40 | 2019 |
| Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA S Dietz, P Christopoulos, Z Yuan, AK Angeles, L Gu, AL Volckmar, ... EBioMedicine 62, 2020 | 36 | 2020 |
| Circulating-free DNA analysis in hepatocellular carcinoma: a promising strategy to improve patients’ management and therapy outcomes S Mezzalira, E De Mattia, M Guardascione, C Dalle Fratte, E Cecchin, ... International Journal of Molecular Sciences 20 (21), 5498, 2019 | 23 | 2019 |
| Clonal selection of a novel deleterious TP53 somatic mutation discovered in ctDNA of a KIT/PDGFRA wild-type gastrointestinal stromal tumor resistant to imatinib C Dalle Fratte, M Guardascione, E De Mattia, E Borsatti, R Boschetto, ... Frontiers in Pharmacology 11, 36, 2020 | 10 | 2020 |
| CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients C Dalle Fratte, S Gagno, R Roncato, J Polesel, M Zanchetta, M Buzzo, ... British Journal of Clinical Pharmacology 89 (3), 1089-1098, 2023 | 8 | 2023 |
| Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis C Dalle Fratte, J Polesel, S Gagno, B Posocco, E De Mattia, R Roncato, ... International Journal of Molecular Sciences 24 (4), 3303, 2023 | 7 | 2023 |
| The use of pharmacogenetics to increase the safety of colorectal cancer patients treated with fluoropyrimidines E De Mattia, R Roncato, C Dalle Fratte, F Ecca, G Toffoli, E Cecchin Cancer Drug Resistance 2 (1), 116, 2019 | 7 | 2019 |
| A panel of tumor biomarkers to predict complete pathological response to neoadjuvant treatment in locally advanced rectal cancer C Dalle Fratte, S Mezzalira, J Polesel, E De Mattia, A Palumbo, ... Oncology Research 28 (9), 847, 2022 | 6 | 2022 |
| Cancer pharmacogenetics: Perspective on newly discovered and implemented predictive biomarkers R Roncato, E Cecchini, C Dalle Fratte, G Decorti, M Del Re, R Franca, ... Pharmadvances 3 (2), 357-368, 2021 | 5 | 2021 |
| SMAD3 host and tumor profiling to identify locally advanced rectal cancer patients at high risk of poor response to neoadjuvant chemoradiotherapy E De Mattia, V Canzonieri, J Polesel, S Mezzalira, C Dalle Fratte, ... Frontiers in Pharmacology 12, 778781, 2021 | 4 | 2021 |
| The genotype for DPYD risk variants in colorectal cancer patients and the related toxicity management costs in clinical practice G Toffoli, F Innocenti, J Polesel, E De Mattia, F Sartor, C Dalle Fratte Clin Pharmacol Ther 10, 2018 | 4 | 2018 |
| Robot-assisted laparoscopic prostatectomy: an economic analysis for decision-making in a university hospital of Northern Italy E Fabbro, S Crivellaro, CF Dalle Fratte, L Vetrugno, G Adani, B Saule, ... Epidemiology Biostatistics and Public Health 12 (1), 1-9, 2015 | 4 | 2015 |
| The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure S Gagno, A Buonadonna, C Dalle Fratte, M Guardascione, M Zanchetta, ... DARU Journal of Pharmaceutical Sciences 31 (2), 267-272, 2023 | 1 | 2023 |
| E-Prescription in the Autonomous Province of Trento: A best practice in Italy CF Dalle Fratte, C Betta, D Spanti, G Zanetti, L Sartori, GM Guarrera litigation 1 (7), 8, 2017 | 1 | 2017 |
| Robot-assisted laparoscopic prostatectomy: a costs and break-even point analysis for decision-making in a university hospital and a regional healthcare system in Northern Italy E Fabbro, S Crivellaro, CF Dalle Fratte, L Vetrugno, G Adani, B Saule, ... Epidemiology, Biostatistics, and Public Health 12 (1), 2015 | 1 | 2015 |
| NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centers M Verzè, AB Bragadin, R Minari, G Pasello, F Perrone, D Scattolin, ... The Journal of Liquid Biopsy, 100143, 2024 | | 2024 |
| Pre-treatment molecular profiling identifies predictive and prognostic fingerprints in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: implications for … S Pollesel, A Lauretta, M Olivieri, L Foltran, M Guardascione, N Milan, ... European Journal of Surgical Oncology 50 (2), 2024 | | 2024 |
| Association of Sodium-Glucose Cotransporter 2 Inhibitors with Osteomyelitis and Other Lower Limb Safety Outcomes in Type 2 Diabetes Mellitus: A Systematic Review and Meta … A Nani, F Carrara, CME Paulesu, C Dalle Fratte, M Padroni, S Enisci, ... Journal of Clinical Medicine 12 (12), 3958, 2023 | | 2023 |
| The economic impact of remote control in patients with implantable cardioverter defibrillators or cardiac resynchronization therapy defibrillators: single center experience M Marini, L Videsott, CF Dalle Fratte, A Francesconi, E Bonvicin, ... Europace 25 (Supplement_1), euad122. 563, 2023 | | 2023 |
